TOKYO--(BUSINESS WIRE)--JapanBridge, Inc. (“JapanBridge”), a specialty pharmaceutical company with operations in Tokyo founded in 2006 by MPM Capital and Itochu Corporation (“Itochu”), announced today that it has entered into a strategic alliance with Kyowa Hakko Kogyo Co., Ltd. (“Kyowa Hakko”) (TOKYO:4151), a major Japanese pharmaceutical company, to collaborate on the commercialization of oncology and oncology supportive care assets in Japan.
